Response to Letter from Wong on Determining the Target Difference in Sample Size Calculations for Randomised Controlled Trials
Overview
Overview
Journal
Trials
Publisher
Biomed Central
Specialties
General Medicine
Pharmacology
Pharmacology
Date
2024 Mar 2
PMID
38431609
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Djulbegovic B, Kumar A, Glasziou P, Miladinovic B, Chalmers I
. Medical research: Trial unpredictability yields predictable therapy gains. Nature. 2013; 500(7463):395-6.
PMC: 3819120.
DOI: 10.1038/500395a.
View
2.
DiMasi J, Feldman L, Seckler A, Wilson A
. Trends in risks associated with new drug development: success rates for investigational drugs. Clin Pharmacol Ther. 2010; 87(3):272-7.
DOI: 10.1038/clpt.2009.295.
View
3.
Wong H
. Minimum important difference is minimally important in sample size calculations. Trials. 2023; 24(1):34.
PMC: 9847050.
DOI: 10.1186/s13063-023-07092-8.
View
4.
Hall J, Mills B, Nguyen H, Hall J
. Methodologic standards in surgical trials. Surgery. 1996; 119(4):466-72.
DOI: 10.1016/s0039-6060(96)80149-8.
View
5.
Cook J, Hislop J, Adewuyi T, Harrild K, Altman D, Ramsay C
. Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review. Health Technol Assess. 2014; 18(28):v-vi, 1-175.
PMC: 4781097.
DOI: 10.3310/hta18280.
View